David Allie, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Lafayette, LANPI 1760489728
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (55.3%), ownership interests and speaking fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 45.2% of the total. Reporting peaked in 2021 at $356,272 and has fallen 97.9% since, to $7,377 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 159 payments — averaging $4191.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$301K
- Anika Therapeutics, Inc.$192K
- Cardiovascular Systems Inc.$68K
- Catheter Precision, Inc. FKA Ra Medical Systems, Inc.$57K
- Angiodynamics, Inc.$18K
- Philips North America LLC$14K
- plus $16K from 19 others
Across 1 payment — averaging $4999.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Veryan Medical Incorporated$5K
What the payments were for
- Consulting fees$57,1259%
- Speaking & faculty fees$81,37512%
- Grants$5,0001%
- Travel & lodging$3880%
- Food & beverage$4,3251%
- Education$6,8171%
- Ownership interest$142,93721%
- Other$368,50855%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 8 | $301,455 |
| Anika Therapeutics, Inc. | 6 | $191,533 |
| Cardiovascular Systems Inc. | 35 | $68,230 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 3 | $57,125 |
| Angiodynamics, Inc. | 22 | $17,840 |
| Philips North America LLC | 16 | $13,917 |
| Convatec Inc. | 2 | $7,222 |
| Biotronik Inc. | 2 | $5,120 |
| Idev Technologies, Inc. | 1 | $1,814 |
| Abbott | 6 | $693 |
| Boston Scientific | 11 | $365 |
| Johnson & Johnson | 19 | $279 |
| Veryan Medical Incorporated | 1 | $276 |
| Medtronic(2 entities) | 4 | $200 |
| Pfizer | 5 | $95 |
| Novartis | 4 | $54 |
| Cardiva Medical, Inc. | 3 | $48 |
| Smith+Nephew | 3 | $46 |
| Silk Road Medical, Inc. | 2 | $37 |
| BD | 1 | $33 |
| Pacira Pharmaceuticals Incorporated | 1 | $29 |
| Tactile Systems Technology Inc | 1 | $22 |
| Kerecis Limited | 1 | $15 |
| Amgen | 1 | $15 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Peripheral Orbital Atherectomy System$68,000
- DABRA$57,125
- Auryon Laser System 100-120 Vac$14,461
- IGT D Peripheral$13,375
- InnovaMatrix AC$7,200
- VenaCure 1470 Pro$1,731
- Auryon$817
- Supera peripheral stent system$693
- BioMimics$276
- Turbo Elite$107
How this compares
$666,475 in reported general payments places this provider in the 95th percentile of 75 thoracic surgery (cardiothoracic vascular surgery) providers in Louisiana.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 410 | $302,109 |
| EliquisApixaban | 56 | $44,125 |
| EntrestoSacubitril/Valsartan | 12 | $23,761 |
| Cilostazol | 648 | $11,974 |
| ClopidogrelClopidogrel Bisulfate | 1,302 | $10,868 |
| BrilintaTicagrelor | 27 | $9,531 |
| Ezetimibe | 424 | $5,985 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 161 | $3,947 |
| Diclofenac Sodium | 225 | $3,827 |
| Gabapentin | 325 | $3,744 |
| Ranolazine ErRanolazine | 90 | $3,436 |
| Pregabalin | 47 | $2,746 |
| Colchicine | 18 | $1,918 |
| Prasugrel Hcl | 16 | $1,732 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 117 | $1,726 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $279 | $302,109410 claims |
| PfizerEliquis | $95 | $44,12556 claims |
| NovartisEntresto | $54 | $23,76112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 75 thoracic surgery (cardiothoracic vascular surgery) providers in Louisiana.
Other thoracic surgery (cardiothoracic vascular surgery) in Lafayette
- Vern KellerLafayette$394K
- Safi HaqLafayette$28K
- Mohamad AllamLafayette$6K
- Mitchell LirtzmanLafayette$2K
- Richard GitterMetairie$1.5M
- Emily CassidyBaton Rouge$1.3M
- Aditya BansalNew Orleans$140K
- Daniel BecklesLake Charles$80K
- Nicholas LeblancBaton Rouge$70K
- Sarah AhmadMonroe$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.